FDA notes problems in study design for PRT061103, investigational drug for heart bypass. Martin Berman-Gorvine reports. http://bit.ly/dY2qHw
9:42 AM - 7 Dec 2010
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.